The Diagnostic Odyssey as Systems Failure

The average time from first symptoms to a diagnosis of hypermobile Ehlers-Danlos syndrome is 10 to 22 years, depending on the study. During that period, the typical person sees 15 clinicians and receives more than 10 alternative diagnoses before someone identifies the connective tissue disorder that explains all of them.

This is not a mystery story. The symptoms are visible. The clinical pattern is recognizable. The system fails to see it because no single specialist is trained to look at the whole picture, and the referral structure sends each symptom to a different department.

Where the System Breaks

A person with hEDS presents with joint pain in their twenties. The general practitioner attributes it to overuse or hypermobility, which is noted but not investigated. The GP may prescribe NSAIDs and suggest exercise. If the person is female, the pain may be attributed to anxiety or stress. This is the first failure point: the GP sees a single symptom, not a system.

The joints continue to sublux. The person is referred to rheumatology. The rheumatologist runs ANA and rheumatoid factor tests, both negative. No inflammatory markers. No autoimmune pattern. The rheumatologist discharges the person with a diagnosis of benign joint hypermobility or early-onset osteoarthritis. This is the second failure point: rheumatology screens for inflammatory and autoimmune disease. hEDS is neither. It falls through the diagnostic criteria the specialty is built to detect.

Gastrointestinal symptoms develop or worsen. Chronic nausea, bloating, constipation alternating with diarrhea, early satiety, reflux. The gastroenterologist diagnoses irritable bowel syndrome. Treatment is dietary modification and proton pump inhibitors. The gastroenterologist does not ask about joint hypermobility, because there is no training pathway that connects IBS to connective tissue. This is the third failure point: the GI system treats the GI symptoms without asking what a 27-year-old's colon has in common with her unstable shoulders.

The person develops tachycardia on standing. Heart racing, lightheadedness, fatigue that worsens upright and improves lying down. Cardiology runs an EKG and echocardiogram, both normal. The tachycardia is attributed to anxiety or deconditioning. If a tilt-table test is performed and postural orthostatic tachycardia syndrome (POTS) is diagnosed, it is treated with beta-blockers and fluid loading. The cardiologist does not connect POTS to the joint hypermobility, the GI dysfunction, or the chronic pain. This is the fourth failure point: POTS is managed as a standalone cardiac condition.

By this point, the person has accumulated diagnoses across four specialties. Joint hypermobility. IBS. Anxiety. POTS. Each specialist has seen one system. None has seen the connective tissue disorder that connects all four.

The person may also have chronic fatigue, migraines, temporomandibular joint dysfunction, slow wound healing, easy bruising, pelvic floor dysfunction, or skin that is unusually soft and stretchy. Each of these generates its own referral. Each referral produces its own isolated diagnosis.

The Psychiatric Detour

In a documented and consistent pattern across healthcare systems, people with undiagnosed hEDS are told their symptoms are psychological. A 2023 study of 505 people with confirmed hEDS found that 75% had received a prior diagnosis of anxiety and 68% a prior diagnosis of depression. These diagnoses are not wrong in the sense that many people with hEDS do experience anxiety and depression. They are wrong in the sense that they are treated as the cause of the physical symptoms rather than as consequences of living with undiagnosed chronic pain and autonomic dysfunction.

The psychiatric attribution is gendered. hEDS is diagnosed in women at ratios as high as 10 to 1 in some clinical series. The extent to which this reflects biological sex differences in connective tissue laxity versus diagnostic bias against women reporting pain is an open question. What is documented is that women with hEDS symptoms are more likely than men to be told the problem is psychological.

In a subset of cases, people with hEDS who seek medical attention for their children's hypermobility-related injuries have been reported to child protective services for suspected Munchausen syndrome by proxy. The bruising, the subluxations, the repeated emergency visits for a child who "looks fine" between episodes produce suspicion in a system that cannot name the condition causing them.

What the System Cannot See

The referral structure of modern medicine is organized by organ system. The GP refers to rheumatology for joints, to gastroenterology for the gut, to cardiology for the heart, to neurology for headaches, to psychiatry for the anxiety that ties them together. Each specialist is trained to diagnose and treat conditions within their system. None is trained to recognize a multi-system connective tissue disorder that manifests differently in each department.

hEDS is not rare in the way that a condition affecting 12 people worldwide is rare. Prevalence estimates range from 1 in 500 to 1 in 5,000 depending on how broadly the diagnostic criteria are applied. At even the conservative end of that range, hEDS is more common than many conditions that every medical student learns to recognize.

The problem is structural. The medical curriculum does not train GPs, rheumatologists, gastroenterologists, or cardiologists to identify hEDS. The Beighton score, the primary screening tool for joint hypermobility, was developed in 1973 from a study of a South African population. It was designed as an epidemiological tool, not a clinical one. It misses most adults whose hypermobility has decreased with age, was not validated across racial groups, and does not capture the most clinically significant presentations. A person with severe multi-system hEDS can score a 2 out of 9 on the Beighton scale and be told they are not hypermobile.

The 2017 diagnostic criteria for hEDS attempted to create a more defined clinical population for research. They include the Beighton score, a checklist of systemic features (skin involvement, marfanoid habitus, family history, musculoskeletal complications), and exclusion of other connective tissue disorders. The criteria narrowed the diagnostic boundary. Many people previously diagnosed with EDS no longer met the revised criteria. Hypermobility Spectrum Disorder (HSD) was introduced as a catch-all category. Many clinicians and affected individuals consider HSD a demotion rather than a diagnosis.

What an EDS-Aware Pathway Looks Like

An EDS-aware clinical pathway would screen for generalized joint hypermobility at the first presentation of unexplained joint pain, especially in young women. It would ask about family history of hypermobility, chronic pain, or joint instability. It would connect GI symptoms, POTS, and chronic pain as potential expressions of a single underlying condition rather than treating each in isolation. It would refer to a geneticist or a connective tissue specialist rather than cycling through rheumatology, gastroenterology, and psychiatry sequentially.

This pathway exists in a handful of centers worldwide. The Ehlers-Danlos Society maintains a directory of knowledgeable providers. The Medical University of South Carolina has a dedicated EDS program. A small number of NHS services in the United Kingdom specialize in hypermobility, though wait times for genetics referrals regularly exceed two years. France has EDS centers of expertise within its national rare disease reference center network.

For the majority of people with hEDS, the pathway does not exist. The average person sees 15 clinicians over 10 to 22 years. Each clinician sees one piece. The person is the only one in the room who sees all of them.

What Data Changes

The diagnostic odyssey is a data problem. The information needed to identify hEDS is generated across those 15 clinical encounters. The joint pain is documented in rheumatology. The IBS is documented in gastroenterology. The POTS is documented in cardiology. The anxiety is documented in psychiatry. The subluxation history is documented in the emergency department. No system aggregates these records into a single view. No algorithm flags the pattern.

Longitudinal, structured health data contributed by the people living with these symptoms could do what the clinical system cannot. When thousands of people contribute their symptom trajectories, their diagnostic histories, their comorbidity patterns, and their treatment responses in a structured format, the multi-system pattern becomes computationally visible. The data identifies the condition the referral system obscures.

hEDS is the condition without a genetic test. Diagnosis depends entirely on clinical recognition. Clinical recognition requires seeing the whole person, across time, across systems. The current structure of healthcare is designed to prevent exactly that view.